Concepedia

Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease

Tyson Burnham, Heidi T. May, Tami L. Bair, Jeffrey Anderson, Brian G. Crandall, Michael J. Cutler, John Day, Roger A. Freedman, Kirk U. Knowlton, Joseph B. Muhlestein,

American Heart Journal · 2021 · 28 citations · 12 references

DOI

Concepts

References

12

Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo

Debra S. Echt, Philip R. Liebson, L. Brent Mitchell et al. · New England Journal of Medicine · 1991 · 3.3K citations · Full text

, , +17

Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogram

Joel Morganroth, Leonard N. Horowitz · The American Journal of Cardiology · 1984 · 280 citations

, , +14

Intravenous flecainide versus Amiedarone fof recent-onset atrial fibrillation

Karl D. Donovan, Bradley Power, Bernard E.F. Hockings et al. · The American Journal of Cardiology · 1995 · 168 citations

, , +11

Prospective Comparison of Flecainide Versus Sotalol for Immediate Cardioversion of Atrial Fibrillation

Johann Reisinger, Edmund Gatterer, Georg Heinze et al. · The American Journal of Cardiology · 1998 · 116 citations

, , +12

Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).

Jeffrey L. Anderson, Edward V. Platia, Alfred P. Hallstrom et al. · Circulation · 1994 · 86 citations · Full text

, , +17